Thousands of Managed Care Professionals Address Complex Issues at AMCP Annual 2024

More than 3,500 managed care professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in New Orleans from April 15-18 for AMCP 2024, the industry’s largest and most impactful annual meeting. Attendees connected with like-minded professionals, discussed the important trends impacting their work, and expanded their horizons through cutting-edge education sessions. 

Our nation faces some serious health care challenges, but we can’t afford to throw up our hands. Solutions will take our collective efforts; they will take partnerships across disciplines and geographies. They will take commitment and collaboration as we look to chip away at and make progress on the issues.

- AMCP CEO, Susan Cantrell, MHL, RPh, CAE

.@amcpceo Susan Cantrell delivered #AMCP2024 remarks highlighting the role that managed care pharmacy, AMCP, and our members play in strengthening #healthequity across the United States. pic.twitter.com/1Os8qnSUEA

— AMCP (@amcporg) April 17, 2024

Health care leaders from different backgrounds spoke to attendees about the importance of managed care pharmacy in the modern health care ecosystem. Kicking off the annual meeting was former NFL long-snapper, magician, and America’s Got Talent finalist Jon Dorenbos who dazzled audiences with his amazing magic and powerful life story. Audiences were also educated by keynote-speaker Doug Long on the future of managed care pharmacy. 

Many members took to social media to visualize their connection of being an MCP. Whether they took a photo for the mosaic wall or used #WeAreMCPs in their social media, attendees were reminded of AMCP's mission to optimize medicine and improve patient health care. So far more than 2,000 photos have been taken and more than 22,000 people have visited and engaged with the #WeAreMCPs campaign.  

AMCP also honored select AMCP Members during the AMCP Awards reception as well as recognized the newest leaders joining the AMCP Board of Directors. AMCP Board of Directors President Christina Barrington, PharmD, also thanked James Hopsicker, RPh, MBA, FAMCP, for his service as AMCP Board President. 

I’m passionate about AMCP and its mission because I’ve seen how important it is to have affordable access to lifesaving and life-enhancing treatments. I saw it firsthand with my own family members who have struggled with their health. I know how important it was that they had the prescriptions that they needed.  I also know how important it is to countless patients and their families across the United States that they have the same access.

- AMCP Board of Directors President Christina Barrington, PharmD

Attendees had the opportunity to hear from industry experts about the issues and developments in the managed care pharmacy industry. From learning about the Inflation Reduction Act, understanding state and federal issues and understanding the world of weight-loss medication, attendees learned more about topical issues. 

Attendees also had the chance to network and connect with other attendees and exhibitors during our Expo. 80 companies (an increase from last year) displayed the latest technology, non-profit work, and more. Thank you to all those who helped showcase the latest in managed care pharmacy. 

#AMCP2024 attendees were able to gain helpful #managedcare insights in short 15-minute spotlight sessions. pic.twitter.com/LZSP7Mmc4c

— AMCP (@amcporg) April 18, 2024

Top takeaways from Annual 2024 sessions: 

1. From 2013-2021, spending on biologics in the U.S. increased from $100B to $260B, or a 160% increase. Potential savings from biosimilars is $54B between 2017-2026.  

2. Cancer drug wastage due to vial size availability results in billions of dollars of excess health care spend in the U.S. In 2021, drug wastage reached $779 million, mainly from oncology.  

3. Nearly 80% of potential 2024 drug approvals can be categorized as specialty.  

4. 2 of the 5 overarching goals of Health People 2030 focus on eliminating health disparities and achieving equity through addressing SDOH.  

5. There are $116.6B projected U.S. sales in 2024 for oncology treatments, with the largest growth in breast cancer treatment.   

6. A wave of new policies focused on drug pricing occurred in 2023, with 831 bills proposed in 52 states (including DC and Puerto Rico) and 150 bills enacted in 44 states.   

7. 2027 will be the first Star Rating year with Health Equity Index applied, based on data from 2024 and 2025.   

8. In 2022, the U.S. obesity market was estimated at $1.5 billion and forecasted to reach $7.6 billion in 2024 and $44 billion by 2030.  

9. Surveys indicate approximately 30-40% of U.S. employer-sponsored insurance plans currently cover GLP-1 RA for weight management.  

10. The gene therapy pipeline is robust, with 5 therapies scheduled for FDA review in 2024, 22 in phase III clinical trials, and over 80 in earlier phases of clinical development.  

Following the success of AMCP 2024, AMCP members and others working in managed care pharmacy have turned their eye towards the highly anticipated AMCP Nexus 2024, which will be held in Las Vegas from Oct. 14-17. The largest fall event in managed care pharmacy is already building to be an epic celebration of the industry. Don’t miss out — sign up to be alerted once registration is open!   

View the full photo album on Facebook. 

Check out what you missed by visiting AMCP Learn to view our top education sessions

Jay Silver
Content Specialist, Marketing
Published on May 2, 2024